238 related articles for article (PubMed ID: 20484486)
1. Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination.
Abdulrahman RM; Verloop H; Hoftijzer H; Verburg E; Hovens GC; Corssmit EP; Reiners C; Gelderblom H; Pereira AM; Kapiteijn E; Romijn JA; Visser TJ; Smit JW
J Clin Endocrinol Metab; 2010 Aug; 95(8):3758-62. PubMed ID: 20484486
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: a prospective evaluation.
Miyake H; Kurahashi T; Yamanaka K; Kondo Y; Muramaki M; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2010; 28(5):515-9. PubMed ID: 19914105
[TBL] [Abstract][Full Text] [Related]
3. Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib.
Riesenbeck LM; Bierer S; Hoffmeister I; Köpke T; Papavassilis P; Hertle L; Thielen B; Herrmann E
World J Urol; 2011 Dec; 29(6):807-13. PubMed ID: 21153827
[TBL] [Abstract][Full Text] [Related]
4. Hypothyroidism in patients with renal cell carcinoma: blessing or curse?
Schmidinger M; Vogl UM; Bojic M; Lamm W; Heinzl H; Haitel A; Clodi M; Kramer G; Zielinski CC
Cancer; 2011 Feb; 117(3):534-44. PubMed ID: 20845482
[TBL] [Abstract][Full Text] [Related]
5. Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones.
Smit JW; Stokkel MP; Pereira AM; Romijn JA; Visser TJ
J Clin Endocrinol Metab; 2007 Jul; 92(7):2496-9. PubMed ID: 17440015
[TBL] [Abstract][Full Text] [Related]
6. Identification of Resistance to Exogenous Thyroxine in Humans.
Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
[No Abstract] [Full Text] [Related]
7. Impaired thyroxine and 3,5,3'-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness.
Vos RA; De Jong M; Bernard BF; Docter R; Krenning EP; Hennemann G
J Clin Endocrinol Metab; 1995 Aug; 80(8):2364-70. PubMed ID: 7629231
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib therapy decreases the clearance of thyrotropin.
Verloop H; Smit JW; Dekkers OM
Eur J Endocrinol; 2013 Feb; 168(2):163-7. PubMed ID: 23125304
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
[TBL] [Abstract][Full Text] [Related]
11. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
12. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
Peterson ME; Melián C; Nichols R
J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
[TBL] [Abstract][Full Text] [Related]
13. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism.
Jørgensen JO; Pedersen SA; Laurberg P; Weeke J; Skakkebaek NE; Christiansen JS
J Clin Endocrinol Metab; 1989 Dec; 69(6):1127-32. PubMed ID: 2685007
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
Chopra IJ; Williams DE; Orgiazzi J; Solomon DH
J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
[TBL] [Abstract][Full Text] [Related]
15. The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, and 3',5'-diiodothyronine in man.
Faber J; Lumholtz IB; Kirkegaard C; Poulsen S; Jørgensen PH; Siersbaek-Nielsen K; Friis T
J Clin Endocrinol Metab; 1985 Dec; 61(6):1093-9. PubMed ID: 4055984
[TBL] [Abstract][Full Text] [Related]
16. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.
Burger A; Dinichert D; Nicod P; Jenny M; Lemarchand-Béraud T; Vallotton MB
J Clin Invest; 1976 Aug; 58(2):255-9. PubMed ID: 783194
[TBL] [Abstract][Full Text] [Related]
17. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.
Borges M; Ingbar SH; Silva JE
Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108
[TBL] [Abstract][Full Text] [Related]
18. The postnatal serum 3,5,3'-triiodothyronine (T3) surge in the rat is largely independent of extrathyroidal 5'-deiodination of thyroxine to T3.
Chanoine JP; Veronikis I; Alex S; Stone S; Fang SL; Leonard JL; Braverman LE
Endocrinology; 1993 Dec; 133(6):2604-9. PubMed ID: 8243283
[TBL] [Abstract][Full Text] [Related]
19. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
Konno N; Morikawa K
J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
[TBL] [Abstract][Full Text] [Related]
20. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
Solter D; Solter M
Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
